Gene · 994
Papers2,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phosphatases in Mitosis: Roles and Regulation. | Biomolecules | 2019 | 30736436 | PubTator, text mining | PubMed |
| FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression. | Sci Rep | 2019 | 30728402 | PubTator, text mining | PubMed |
| miR-148a regulates expression of the transferrin receptor 1 in hepatocellular carcinoma. | Sci Rep | 2019 | 30728365 | PubTator, text mining | PubMed |
| Bladder cancer stage-associated hub genes revealed by WGCNA co-expression network analysis. | Hereditas | 2019 | 30723390 | PubTator, text mining | PubMed |
| High FOXM1 expression is a prognostic marker for poor clinical outcomes in prostate cancer. | J Cancer | 2019 | 30719174 | PubTator, text mining | PubMed |
| Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression. | Sci Rep | 2019 | 30718768 | PubTator, text mining | PubMed |
| PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells. | Oncogene | 2019 | 30705403 | PubTator, text mining | PubMed |
| Transcriptional Analysis of Immunohistochemically Defined Subgroups of Non-Muscle-Invasive Papillary High-Grade Upper Tract Urothelial Carcinoma. | Int J Mol Sci | 2019 | 30699951 | PubTator, text mining | PubMed |
| Review of transcriptomic responses to hexavalent chromium exposure in lung cells supports a role of epigenetic mediators in carcinogenesis. | Toxicol Lett | 2019 | 30690063 | PubTator, text mining | PubMed |
| Deciphering the Molecular Mechanisms Sustaining the Estrogenic Activity of the Two Major Dietary Compounds Zearalenone and Apigenin in ER-Positive Breast Cancer Cell Lines. | Nutrients | 2019 | 30678243 | PubTator, text mining | PubMed |
| Synthesis of Dual Target CPT-Ala-Nor Conjugates and Their Biological Activity Evaluation. | Anticancer Agents Med Chem | 2019 | 30663574 | PubTator, text mining | PubMed |
| rs187960998 polymorphism in miR-211 prevents development of human colon cancer by deregulation of 3'UTR in CHD5. | Onco Targets Ther | 2019 | 30655677 | PubTator, text mining | PubMed |
| Identification of hub genes and outcome in colon cancer based on bioinformatics analysis. | Cancer Manag Res | 2019 | 30643458 | PubTator, text mining | PubMed |
| Discovery of Small-Molecule Inhibitors of the HSP90-Calcineurin-NFAT Pathway against Glioblastoma. | Cell Chem Biol | 2019 | 30639261 | PubTator, text mining | PubMed |
| Long-Read RNA Sequencing Identifies Alternative Splice Variants in Hepatocellular Carcinoma and Tumor-Specific Isoforms. | Hepatology | 2019 | 30637779 | PubTator, text mining | PubMed |
| Shikonin inhibits cancer cell cycling by targeting Cdc25s. | BMC Cancer | 2019 | 30616572 | PubTator, text mining | PubMed |
| Hepatic transcriptional dose-response analysis of male and female Fischer rats exposed to hexabromocyclododecane. | Food Chem Toxicol | 2019 | 30594549 | PubTator, text mining | PubMed |
| Inhibition of miR-148a-3p resists hepatocellular carcinoma progress of hepatitis C virus infection through suppressing c-Jun and MAPK pathway. | J Cell Mol Med | 2019 | 30565389 | PubTator, text mining | PubMed |
| TIAR marks nuclear G2/M transition granules and restricts CDK1 activity under replication stress. | EMBO Rep | 2019 | 30538118 | PubTator, text mining | PubMed |
| The subcellular location of cyclin B1 and CDC25 associated with the formation of polyploid giant cancer cells and their clinicopathological significance. | Lab Invest | 2019 | 30487595 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/994/papers?page=42